FDA Recall: Medtronic Announces Voluntary Worldwide Recall of its Stratamr Adjustable Valves and Shunts

Medtronic Announces Voluntary Worldwide Recall of its Stratamr Adjustable Valves and Shunts

Medtronic plc (NYSE: MDT) announced that on February 22, 2017 it notified customers of a voluntary recall of all unused units of the StrataMR adjustable valves and shunts. These products are manufactured and marketed by Medtronic's Neurosurgery business, which is part of the Brain Therapies division of the company's Restorative Therapies Group.

For detailed information pertaining to this Recalls, Market Withdrawals and Safety Alerts message, please click the link at the beginning of this bulletin.

Helene D. Clayton-Jeter, O.D.
Office of Health and Constituent Affairs
Food and Drug Administration